Dr. Klafter is Board Certified in Hematology and Medical Oncology. New York Magazine included him in their 2012 list of New York's Best Doctors. After college at The University of Pennsylvania, he went to medical school at New York University, graduating in 1994. He completed residency and was a Chief Resident at Bellevue Hospital/NYU. After fellowship at Emory University, he returned to New York in 2001.
Dr. Klafter is Board Certified in Hematology and Medical Oncology. New York Magazine included him in their 2012 list of New York's Best Doctors. After college at The University of Pennsylvania, he went to medical school at New York University, graduating in 1994. He completed residency and was a Chief Resident at Bellevue Hospital/NYU. After fellowship at Emory University, he returned to New York in 2001.
Dr. Klafter is an attending physician at Mount Sinai Medical Center and Lenox Hill Hospital. He holds an appointment as Assistant Clinical Professor at the Mount Sinai School of Medicine. Active in the teaching of medical students, residents and fellows, he has been awarded the Leslie Kuhn Memorial Award for Service to the Department of Medicine.
Dr. Klafter specializes in the close care of his patients. Always available and invested in the best outcomes, he seeks to provide intimate, personalized care. This remains the hallmark of his practice.
He is active in the American Society of Clinical Oncology, American Society of Hematology and NY State Medical Society. Listed in America's Top Oncologists, Best Doctors and New York Super Doctors, he looks to give every patient the best possible care required in their time of illness.
Emory University Hospital, Fellowship in Hematology
Emory University Hospital, Fellowship in Oncology
New York University Medical Center, Residency in Internal Medicine
Medical School - New York University
Emory University Hospital, Fellowship in Hematology
Emory University Hospital, Fellowship in Oncology
New York University Medical Center, Residency in Internal Medicine
Board Certifications
Hematology (Internal Medicine)
Medical Oncology (Internal Medicine)
Hematology (Internal Medicine)
Medical Oncology (Internal Medicine)
Awards and Publications
New York Super Doctors
Best Doctors
America's Top Oncologists
Perioperative Care in Adult Cardiac Surgery, In Filsoufi, Adams (eds)
Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a)...Read More
New York Super Doctors
Best Doctors
America's Top Oncologists
Perioperative Care in Adult Cardiac Surgery, In Filsoufi, Adams (eds)
Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med.2002 Jan;8(1):1-8. PMID: 11984000
Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 2002 Jan 22;99(2):715-20 PMID 11805326
Hypoxia-inducible factor 1 as a novel diagnostic and their therapeutic target in human cancers. Recent Res. Devel. Cancer,3(2001):49-68
Regulations of angiogenesis and tumorigensis by signal Transduction cascades: lessons from benign and malignant endothelial tumors. J investing Dermatol Symp Proc. 2000 Dec;5(1):79-82 Review. PMID: 11147680
Genetic and Signal Transduction Analysis of a Nickel Sulfide-Induced Sarcoma.
